Kagawa, Japan

Fushimi Pharmaceutical Company, Limited

Calculating rank
USPTO Granted Patents = 7

% Expired Patents = 57.1


Trademarks = 1

Forward Citations = 21

Loading Chart...
Loading Chart...

26 inventors (with patents filed for the assignee):

goldMedal Masaaki Tokuda (2 out of 18 patents)

silverMedal Ken Izumori (2 out of 32 patents)

bronzeMedal Keiji Tsusaki (2 out of 31 patents)

4.  Masaaki Ueki (2 out of 3 patents)

5.  Yutaka Ishida (2 out of 3 patents)

6.  Osamu Miyamoto (2 out of 2 patents)

7.  Toshifumi Itano (2 out of 2 patents)

8.  Toshihiko Ishida (2 out of 2 patents)

9.  Koji Murao (2 out of 3 patents)

10.  Taizo Tasaka (2 out of 2 patents)

11.  Gan Muneuchi (2 out of 2 patents)

12.  Fuminori Yamaguchi (2 out of 2 patents)

13.  Terukazu Tanaka (2 out of 2 patents)

14.  Kazuyuki Hirooka (2 out of 2 patents)

15.  Tomohiko Taminato (2 out of 2 patents)


7 patents:

Company Overview
Fushimi Pharmaceutical Company, Limited is a leading Japanese pharmaceutical company that specializes in the development and manufacturing of a wide range of pharmaceutical products. With a strong focus on research and innovation, Fushimi is dedicated to improving the quality of life for patients around the world. Through their commitment to excellence and customer satisfaction, Fushimi continues to be a trusted partner in the global healthcare industry.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

7 Patents

#13 in Kagawa

#5,462 in Japan

Kagawa, JP
Kagawa, Japan
Forward Citations = 21

26 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Fushimi Pharmaceutical Company, Limited. Retrieved from https://idiyas.com/company/fushimi-pharmaceutical-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…